(MENAFN- GlobeNewsWire - Nasdaq)
NEW YORK, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Talos Energy Inc. (NYSE: TALO)'s merger with EnVen Energy Corporation. If you are a Talos shareholder, click here to learn more about your rights and options .
CyberOptics Corporation (NASDAQ: CYBE)'s sale to Nordson Corporation for $54.00 per share. If you are a CyberOptics shareholder, click here to learn more about your rights and options .
Terminix Global Holdings, Inc. (NYSE: TMX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Rentokil Initial plc. If you are a Terminix shareholder, click here to learn more about your rights and options .
Ra Medical Systems, Inc. (NYSE: RMED)'s merger with Catheter Precision, Inc. If you are a Ra Medical shareholder, click here to learn more about your rights and options .
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email or .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
Tags Class Action
MENAFN23092022004107003653ID1104913941
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.